Gilead Sciences, a California pharmaceutical company, awarded $7.5 million to five healthcare organizations to advance research on HIV.
"Finding a cure for HIV is a formidable challenge to the scientific community. Together with our newest grant recipients, all of whom have a record of excellence in their research, we can take collective steps to help end this devastating epidemic," said William Lee, PhD, executive vice president of research at Gilead Sciences.
The organizations that received the grants are: San Francisco-based University of California; Worchester-based University of Massachusetts Medical School; Frederick (Md.) National Laboratory for Cancer Research, Aids and Cancer Virus Program, Boston-based Dana-Farber Cancer Institute; and the University of Montpellier's Institute of Human Genetics in France.
Gilead Sciences also granted more than $22 million for HIV research in January 2017.